2019 Controversies Symposium - Friday, August 9

Attendee Evaluation

Please rate the FACULTY in their substantive knowledge, delivery style and presentation quality.

Question Title

* 1. RF Microneedling: More Than the Emperor's New Clothes?

	EXCELLENT	VERY GOOD	SATISFACTORY	BELOW AVERAGE	POOR
Anne Chapas, MD	Anne Chapas, MD EXCELLENT	Anne Chapas, MD VERY GOOD	Anne Chapas, MD SATISFACTORY	Anne Chapas, MD BELOW AVERAGE	Anne Chapas, MD POOR
Christine Dierickx, MD	Christine Dierickx, MD EXCELLENT	Christine Dierickx, MD VERY GOOD	Christine Dierickx, MD SATISFACTORY	Christine Dierickx, MD BELOW AVERAGE	Christine Dierickx, MD POOR
Macrene Alexiades, MD, PhD	Macrene Alexiades, MD, PhD EXCELLENT	Macrene Alexiades, MD, PhD VERY GOOD	Macrene Alexiades, MD, PhD SATISFACTORY	Macrene Alexiades, MD, PhD BELOW AVERAGE	Macrene Alexiades, MD, PhD POOR
E. Victor Ross, MD	E. Victor Ross, MD EXCELLENT	E. Victor Ross, MD VERY GOOD	E. Victor Ross, MD SATISFACTORY	E. Victor Ross, MD BELOW AVERAGE	E. Victor Ross, MD POOR
Robert Weiss, MD (panelist)	Robert Weiss, MD (panelist) EXCELLENT	Robert Weiss, MD (panelist) VERY GOOD	Robert Weiss, MD (panelist) SATISFACTORY	Robert Weiss, MD (panelist) BELOW AVERAGE	Robert Weiss, MD (panelist) POOR
Ashish Bhatia, MD (panelist)	Ashish Bhatia, MD (panelist) EXCELLENT	Ashish Bhatia, MD (panelist) VERY GOOD	Ashish Bhatia, MD (panelist) SATISFACTORY	Ashish Bhatia, MD (panelist) BELOW AVERAGE	Ashish Bhatia, MD (panelist) POOR
Henry Chan, MD (panelist)	Henry Chan, MD (panelist) EXCELLENT	Henry Chan, MD (panelist) VERY GOOD	Henry Chan, MD (panelist) SATISFACTORY	Henry Chan, MD (panelist) BELOW AVERAGE	Henry Chan, MD (panelist) POOR

Question Title

* 2. Social Media in the Aesthetic Landscape

	EXCELLENT	VERY GOOD	SATISFACTORY	BELOW AVERAGE	POOR
Neelam Vashi, MD	Neelam Vashi, MD EXCELLENT	Neelam Vashi, MD VERY GOOD	Neelam Vashi, MD SATISFACTORY	Neelam Vashi, MD BELOW AVERAGE	Neelam Vashi, MD POOR
Katherine Fields, MD	Katherine Fields, MD EXCELLENT	Katherine Fields, MD VERY GOOD	Katherine Fields, MD SATISFACTORY	Katherine Fields, MD BELOW AVERAGE	Katherine Fields, MD POOR
Zakia Rahman, MD	Zakia Rahman, MD EXCELLENT	Zakia Rahman, MD VERY GOOD	Zakia Rahman, MD SATISFACTORY	Zakia Rahman, MD BELOW AVERAGE	Zakia Rahman, MD POOR
Elizabeth Tanzi, MD	Elizabeth Tanzi, MD EXCELLENT	Elizabeth Tanzi, MD VERY GOOD	Elizabeth Tanzi, MD SATISFACTORY	Elizabeth Tanzi, MD BELOW AVERAGE	Elizabeth Tanzi, MD POOR
Lauren Bonati, MD (panelist)	Lauren Bonati, MD (panelist) EXCELLENT	Lauren Bonati, MD (panelist) VERY GOOD	Lauren Bonati, MD (panelist) SATISFACTORY	Lauren Bonati, MD (panelist) BELOW AVERAGE	Lauren Bonati, MD (panelist) POOR
Christopher Zachary, MD (panelist)	Christopher Zachary, MD (panelist) EXCELLENT	Christopher Zachary, MD (panelist) VERY GOOD	Christopher Zachary, MD (panelist) SATISFACTORY	Christopher Zachary, MD (panelist) BELOW AVERAGE	Christopher Zachary, MD (panelist) POOR
George Hruza, MD, MBA (panelist)	George Hruza, MD, MBA (panelist) EXCELLENT	George Hruza, MD, MBA (panelist) VERY GOOD	George Hruza, MD, MBA (panelist) SATISFACTORY	George Hruza, MD, MBA (panelist) BELOW AVERAGE	George Hruza, MD, MBA (panelist) POOR
Jeffrey Hsu, MD (panelist)	Jeffrey Hsu, MD (panelist) EXCELLENT	Jeffrey Hsu, MD (panelist) VERY GOOD	Jeffrey Hsu, MD (panelist) SATISFACTORY	Jeffrey Hsu, MD (panelist) BELOW AVERAGE	Jeffrey Hsu, MD (panelist) POOR

Question Title

* 3. Controversies: Complex Cases, Complications and Comments

	EXCELLENT	VERY GOOD	SATISFACTORY	BELOW AVERAGE	POOR
Mona Sadeghpour, MD - More on Delayed Onset Filler Nodules	Mona Sadeghpour, MD - More on Delayed Onset Filler Nodules EXCELLENT	Mona Sadeghpour, MD - More on Delayed Onset Filler Nodules VERY GOOD	Mona Sadeghpour, MD - More on Delayed Onset Filler Nodules SATISFACTORY	Mona Sadeghpour, MD - More on Delayed Onset Filler Nodules BELOW AVERAGE	Mona Sadeghpour, MD - More on Delayed Onset Filler Nodules POOR
Elizabeth Tanzi, MD - Blindness from Fillers: More Common Than We Think?	Elizabeth Tanzi, MD - Blindness from Fillers: More Common Than We Think? EXCELLENT	Elizabeth Tanzi, MD - Blindness from Fillers: More Common Than We Think? VERY GOOD	Elizabeth Tanzi, MD - Blindness from Fillers: More Common Than We Think? SATISFACTORY	Elizabeth Tanzi, MD - Blindness from Fillers: More Common Than We Think? BELOW AVERAGE	Elizabeth Tanzi, MD - Blindness from Fillers: More Common Than We Think? POOR
Neelam Vashi, MD - Filler Induced Granulomas	Neelam Vashi, MD - Filler Induced Granulomas EXCELLENT	Neelam Vashi, MD - Filler Induced Granulomas VERY GOOD	Neelam Vashi, MD - Filler Induced Granulomas SATISFACTORY	Neelam Vashi, MD - Filler Induced Granulomas BELOW AVERAGE	Neelam Vashi, MD - Filler Induced Granulomas POOR
Macrene Alexiades, MD, PhD - Preventing Complications When Combining Treatments	Macrene Alexiades, MD, PhD - Preventing Complications When Combining Treatments EXCELLENT	Macrene Alexiades, MD, PhD - Preventing Complications When Combining Treatments VERY GOOD	Macrene Alexiades, MD, PhD - Preventing Complications When Combining Treatments SATISFACTORY	Macrene Alexiades, MD, PhD - Preventing Complications When Combining Treatments BELOW AVERAGE	Macrene Alexiades, MD, PhD - Preventing Complications When Combining Treatments POOR
Joel Cohen, MD - Preventing Filler Induced Impending Necrosis	Joel Cohen, MD - Preventing Filler Induced Impending Necrosis EXCELLENT	Joel Cohen, MD - Preventing Filler Induced Impending Necrosis VERY GOOD	Joel Cohen, MD - Preventing Filler Induced Impending Necrosis SATISFACTORY	Joel Cohen, MD - Preventing Filler Induced Impending Necrosis BELOW AVERAGE	Joel Cohen, MD - Preventing Filler Induced Impending Necrosis POOR
Robert Weiss, MD - Simple Technology to Minimize Risk of Arterial Compromise	Robert Weiss, MD - Simple Technology to Minimize Risk of Arterial Compromise EXCELLENT	Robert Weiss, MD - Simple Technology to Minimize Risk of Arterial Compromise VERY GOOD	Robert Weiss, MD - Simple Technology to Minimize Risk of Arterial Compromise SATISFACTORY	Robert Weiss, MD - Simple Technology to Minimize Risk of Arterial Compromise BELOW AVERAGE	Robert Weiss, MD - Simple Technology to Minimize Risk of Arterial Compromise POOR
Mathew Avram, MD, JD (panelist)	Mathew Avram, MD, JD (panelist) EXCELLENT	Mathew Avram, MD, JD (panelist) VERY GOOD	Mathew Avram, MD, JD (panelist) SATISFACTORY	Mathew Avram, MD, JD (panelist) BELOW AVERAGE	Mathew Avram, MD, JD (panelist) POOR
Gary Monheit, MD (panelist)	Gary Monheit, MD (panelist) EXCELLENT	Gary Monheit, MD (panelist) VERY GOOD	Gary Monheit, MD (panelist) SATISFACTORY	Gary Monheit, MD (panelist) BELOW AVERAGE	Gary Monheit, MD (panelist) POOR
Omar Ibrahimi, MD, PhD (panelist)	Omar Ibrahimi, MD, PhD (panelist) EXCELLENT	Omar Ibrahimi, MD, PhD (panelist) VERY GOOD	Omar Ibrahimi, MD, PhD (panelist) SATISFACTORY	Omar Ibrahimi, MD, PhD (panelist) BELOW AVERAGE	Omar Ibrahimi, MD, PhD (panelist) POOR
Brian Biesman, MD, FACS (panelist)	Brian Biesman, MD, FACS (panelist) EXCELLENT	Brian Biesman, MD, FACS (panelist) VERY GOOD	Brian Biesman, MD, FACS (panelist) SATISFACTORY	Brian Biesman, MD, FACS (panelist) BELOW AVERAGE	Brian Biesman, MD, FACS (panelist) POOR

Question Title

* 4. Controversies: Pearls @ Controversies & Conversations

	EXCELLENT	VERY GOOD	SATISFACTORY	BELOW AVERAGE	POOR
James Newman, MD, FACS - Better Filler Blending	James Newman, MD, FACS - Better Filler Blending EXCELLENT	James Newman, MD, FACS - Better Filler Blending VERY GOOD	James Newman, MD, FACS - Better Filler Blending SATISFACTORY	James Newman, MD, FACS - Better Filler Blending BELOW AVERAGE	James Newman, MD, FACS - Better Filler Blending POOR
Lisa Kellet, MD, FRCPC - HA Fillers for Reconstructive Purposes	Lisa Kellet, MD, FRCPC - HA Fillers for Reconstructive Purposes EXCELLENT	Lisa Kellet, MD, FRCPC - HA Fillers for Reconstructive Purposes VERY GOOD	Lisa Kellet, MD, FRCPC - HA Fillers for Reconstructive Purposes SATISFACTORY	Lisa Kellet, MD, FRCPC - HA Fillers for Reconstructive Purposes BELOW AVERAGE	Lisa Kellet, MD, FRCPC - HA Fillers for Reconstructive Purposes POOR
Roy Geronemus, MD - Nitrous Oxide	Roy Geronemus, MD - Nitrous Oxide EXCELLENT	Roy Geronemus, MD - Nitrous Oxide VERY GOOD	Roy Geronemus, MD - Nitrous Oxide SATISFACTORY	Roy Geronemus, MD - Nitrous Oxide BELOW AVERAGE	Roy Geronemus, MD - Nitrous Oxide POOR
Kevin Smith, MD, FRCPC - Methoxyflurane	Kevin Smith, MD, FRCPC - Methoxyflurane EXCELLENT	Kevin Smith, MD, FRCPC - Methoxyflurane VERY GOOD	Kevin Smith, MD, FRCPC - Methoxyflurane SATISFACTORY	Kevin Smith, MD, FRCPC - Methoxyflurane BELOW AVERAGE	Kevin Smith, MD, FRCPC - Methoxyflurane POOR
Anne Chapas, MD - Do I Really Need Eye Shields?	Anne Chapas, MD - Do I Really Need Eye Shields? EXCELLENT	Anne Chapas, MD - Do I Really Need Eye Shields? VERY GOOD	Anne Chapas, MD - Do I Really Need Eye Shields? SATISFACTORY	Anne Chapas, MD - Do I Really Need Eye Shields? BELOW AVERAGE	Anne Chapas, MD - Do I Really Need Eye Shields? POOR
Christopher Zachary, MD - Does CME Get in the Way of Medial Education?	Christopher Zachary, MD - Does CME Get in the Way of Medial Education? EXCELLENT	Christopher Zachary, MD - Does CME Get in the Way of Medial Education? VERY GOOD	Christopher Zachary, MD - Does CME Get in the Way of Medial Education? SATISFACTORY	Christopher Zachary, MD - Does CME Get in the Way of Medial Education? BELOW AVERAGE	Christopher Zachary, MD - Does CME Get in the Way of Medial Education? POOR
David McDaniel, MD - Opsin 3 Receptor Induced Pigment Expression and Melasma	David McDaniel, MD - Opsin 3 Receptor Induced Pigment Expression and Melasma EXCELLENT	David McDaniel, MD - Opsin 3 Receptor Induced Pigment Expression and Melasma VERY GOOD	David McDaniel, MD - Opsin 3 Receptor Induced Pigment Expression and Melasma SATISFACTORY	David McDaniel, MD - Opsin 3 Receptor Induced Pigment Expression and Melasma BELOW AVERAGE	David McDaniel, MD - Opsin 3 Receptor Induced Pigment Expression and Melasma POOR
Brooke Sikora, MD (panelist)	Brooke Sikora, MD (panelist) EXCELLENT	Brooke Sikora, MD (panelist) VERY GOOD	Brooke Sikora, MD (panelist) SATISFACTORY	Brooke Sikora, MD (panelist) BELOW AVERAGE	Brooke Sikora, MD (panelist) POOR
Brian Zelickson, MD (panelist)	Brian Zelickson, MD (panelist) EXCELLENT	Brian Zelickson, MD (panelist) VERY GOOD	Brian Zelickson, MD (panelist) SATISFACTORY	Brian Zelickson, MD (panelist) BELOW AVERAGE	Brian Zelickson, MD (panelist) POOR
Henry Chan, MD (panelist)	Henry Chan, MD (panelist) EXCELLENT	Henry Chan, MD (panelist) VERY GOOD	Henry Chan, MD (panelist) SATISFACTORY	Henry Chan, MD (panelist) BELOW AVERAGE	Henry Chan, MD (panelist) POOR
Kristen Kelly, MD (panelist)	Kristen Kelly, MD (panelist) EXCELLENT	Kristen Kelly, MD (panelist) VERY GOOD	Kristen Kelly, MD (panelist) SATISFACTORY	Kristen Kelly, MD (panelist) BELOW AVERAGE	Kristen Kelly, MD (panelist) POOR

Question Title

* 5. Hot Topic: Melasma

	EXCELLENT	VERY GOOD	SATISFACTORY	BELOW AVERAGE	POOR
Chee Goh, MD	Chee Goh, MD EXCELLENT	Chee Goh, MD VERY GOOD	Chee Goh, MD SATISFACTORY	Chee Goh, MD BELOW AVERAGE	Chee Goh, MD POOR
Andrew Alexis, MD	Andrew Alexis, MD EXCELLENT	Andrew Alexis, MD VERY GOOD	Andrew Alexis, MD SATISFACTORY	Andrew Alexis, MD BELOW AVERAGE	Andrew Alexis, MD POOR
Mona Sadeghpour, MD	Mona Sadeghpour, MD EXCELLENT	Mona Sadeghpour, MD VERY GOOD	Mona Sadeghpour, MD SATISFACTORY	Mona Sadeghpour, MD BELOW AVERAGE	Mona Sadeghpour, MD POOR
Henry Chan, MD	Henry Chan, MD EXCELLENT	Henry Chan, MD VERY GOOD	Henry Chan, MD SATISFACTORY	Henry Chan, MD BELOW AVERAGE	Henry Chan, MD POOR

Question Title

* 6. Hot Topic: NanoPulse Technology

	EXCELLENT	VERY GOOD	SATISFACTORY	BELOW AVERAGE	POOR
Thomas Rohrer, MD	Thomas Rohrer, MD EXCELLENT	Thomas Rohrer, MD VERY GOOD	Thomas Rohrer, MD SATISFACTORY	Thomas Rohrer, MD BELOW AVERAGE	Thomas Rohrer, MD POOR
Girish Munavalli, MD	Girish Munavalli, MD EXCELLENT	Girish Munavalli, MD VERY GOOD	Girish Munavalli, MD SATISFACTORY	Girish Munavalli, MD BELOW AVERAGE	Girish Munavalli, MD POOR
Brian Zelickson, MD	Brian Zelickson, MD EXCELLENT	Brian Zelickson, MD VERY GOOD	Brian Zelickson, MD SATISFACTORY	Brian Zelickson, MD BELOW AVERAGE	Brian Zelickson, MD POOR

Question Title

* 7. Were the presentations objective and free of commercial bias?

Yes

If you answered no, please indicated what was perceived as commercial bias (non-educational and/or promotional) and the name of the presenter or the presentation title.

Thank you for completing this evaluation for Friday's sessions.

You will receive an evaluation for Saturday sessions at the beginning of the day.